JP Stock MarketDetailed Quotes

6457 GLORY

Watchlist

2595.0
-17.0-0.65%

20min DelayMarket Closed Dec 30 15:30 JST

152.94BMarket Cap4.86P/E (Static)

GLORY Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

33.14%92.78B

45.58%372.48B

45.79%112.77B

53.50%101.87B

49.01%88.16B

31.52%69.68B

12.93%255.86B

14.00%77.35B

19.45%66.36B

7.69%59.16B

Cost of revenue

31.73%52.69B

27.49%209.89B

28.99%65.4B

36.55%55.78B

19.84%48.71B

23.34%40B

20.34%164.63B

15.42%50.7B

26.40%40.85B

24.44%40.65B

Gross profit

35.06%40.09B

78.22%162.59B

77.74%47.37B

80.65%46.09B

113.07%39.45B

44.43%29.68B

1.63%91.23B

11.40%26.65B

9.79%25.51B

-16.89%18.51B

Operating expense

15.66%29.53B

22.72%111.31B

28.25%31.43B

22.81%27.54B

20.57%26.81B

18.54%25.53B

14.00%90.7B

9.59%24.51B

10.24%22.42B

19.76%22.24B

Operating profit

154.35%10.56B

9,723.18%51.28B

643.52%15.94B

500.42%18.55B

439.11%12.63B

520.57%4.15B

-94.88%522M

37.26%2.14B

6.59%3.09B

-200.54%-3.73B

Net non-operating interest income (expenses)

-98.48%-655M

-70.62%-1.68B

-79.59%-616M

-36.29%-323M

-72.92%-415M

-97.60%-330M

-137.26%-987M

-246.46%-343M

-211.84%-237M

-110.53%-240M

Non-operating interest income

-37.04%34M

57.62%238M

--0

243.59%134M

47.06%50M

38.46%54M

-31.98%151M

-33.90%39M

-37.10%39M

-20.93%34M

Non-operating interest expense

79.43%689M

68.89%1.92B

61.26%616M

65.58%457M

69.71%465M

86.41%384M

78.37%1.14B

141.77%382M

100.00%276M

74.52%274M

Net investment income

-211.62%-701M

-34.26%-721M

-203.98%-1.07B

92.73%-20M

-404.71%-259M

12,460.00%628M

-185.37%-537M

-191.19%-352M

-278.57%-275M

204.94%85M

Gain(Loss) on financial instruments designated as cash flow hedges

1.44B

-12M

Gain(Loss) on derecognition of available-for-sale financial assets

221.74%140M

-86.00%7M

121.48%29M

456.67%107M

-3M

-139.58%-115M

338.10%50M

-2,600.00%-135M

-130.77%-30M

Income from associates and other participating interests

116.46%39M

69.24%-916M

92.33%-172M

12.58%-264M

-80.00%-243M

20.74%-237M

-5,034.48%-2.98B

-2,569.05%-2.24B

-2,845.45%-302M

-375.51%-135M

Special income (charges)

-722.86%-654M

53.92%-1.76B

92.70%-171M

84.66%-225M

-14,620.00%-1.47B

2,200.00%105M

-215.03%-3.83B

-3,620.63%-2.34B

-139.04%-1.47B

93.59%-10M

Less:Restructuring and mergern&acquisition

--657M

----

Less:Other special charges

97.14%-3M

1,680.00%267M

7,550.00%153M

11,350.00%225M

-160.00%-6M

-2,200.00%-105M

100.32%15M

104.08%2M

99.96%-2M

433.33%10M

Less:Write off

----

-60.75%1.5B

-99.23%18M

--0

----

194.97%3.81B

1,991.07%2.34B

80.25%1.47B

----

Other non-operating income (expenses)

-58.88%44M

361.96%482M

242.59%606M

189.86%400M

-4,953.85%-631M

18.89%107M

-440.74%-184M

-94.06%-425M

-6.76%138M

-80.60%13M

Income before tax

95.23%8.63B

802.81%46.81B

512.29%14.53B

700.57%18.15B

340.53%9.72B

424.05%4.42B

-148.69%-6.66B

-341.14%-3.52B

-67.08%2.27B

-216.86%-4.04B

Income tax

29.12%2.85B

692.76%16.55B

459.07%5.52B

803.45%5.49B

6,693.88%3.33B

397.74%2.21B

-66.53%2.09B

-27.05%987M

-74.12%608M

-96.53%49M

Net income

161.16%5.78B

446.00%30.27B

299.71%9.01B

662.41%12.66B

256.26%6.39B

222.46%2.21B

-217.52%-8.75B

-4,275.93%-4.51B

-63.41%1.66B

-299.90%-4.09B

Net income continuous operations

161.04%5.78B

446.01%30.27B

299.71%9.01B

662.87%12.66B

256.26%6.39B

222.58%2.22B

-217.50%-8.75B

-4,275.93%-4.51B

-63.44%1.66B

-299.90%-4.09B

Noncontrolling interests

-81.82%38M

-24.71%594M

-28.99%240M

-62.99%57M

-34.33%88M

28.22%209M

-23.69%789M

-11.05%338M

-48.49%154M

-42.49%134M

Net income attributable to the company

186.43%5.74B

411.11%29.67B

280.82%8.77B

736.52%12.6B

249.25%6.3B

201.67%2.01B

-248.80%-9.54B

-1,689.30%-4.85B

-64.46%1.51B

-333.06%-4.22B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

186.43%5.74B

411.11%29.67B

280.82%8.77B

736.52%12.6B

249.25%6.3B

201.67%2.01B

-248.80%-9.54B

-1,689.30%-4.85B

-64.46%1.51B

-333.06%-4.22B

Gross dividend payment

Basic earnings per share

185.94%103.14

419.49%533.62

284.16%157.66

821.64%226.54

255.74%113.35

208.61%36.07

-257.54%-167.02

-1,810.94%-85.61

-64.93%24.58

-342.76%-72.78

Diluted earnings per share

185.94%103.14

419.49%533.62

280.74%157.6528

821.60%226.5288

251.71%112.4233

208.61%36.07

-257.54%-167.02

-1,847.01%-87.2259

-64.75%24.58

-348.53%-74.1034

Dividend per share

55.88%106

94.12%66

17.65%40

0.00%68

0.00%34

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	33.14%92.78B	45.58%372.48B	45.79%112.77B	53.50%101.87B	49.01%88.16B	31.52%69.68B	12.93%255.86B	14.00%77.35B	19.45%66.36B	7.69%59.16B
Cost of revenue	31.73%52.69B	27.49%209.89B	28.99%65.4B	36.55%55.78B	19.84%48.71B	23.34%40B	20.34%164.63B	15.42%50.7B	26.40%40.85B	24.44%40.65B
Gross profit	35.06%40.09B	78.22%162.59B	77.74%47.37B	80.65%46.09B	113.07%39.45B	44.43%29.68B	1.63%91.23B	11.40%26.65B	9.79%25.51B	-16.89%18.51B
Operating expense	15.66%29.53B	22.72%111.31B	28.25%31.43B	22.81%27.54B	20.57%26.81B	18.54%25.53B	14.00%90.7B	9.59%24.51B	10.24%22.42B	19.76%22.24B
Operating profit	154.35%10.56B	9,723.18%51.28B	643.52%15.94B	500.42%18.55B	439.11%12.63B	520.57%4.15B	-94.88%522M	37.26%2.14B	6.59%3.09B	-200.54%-3.73B
Net non-operating interest income (expenses)	-98.48%-655M	-70.62%-1.68B	-79.59%-616M	-36.29%-323M	-72.92%-415M	-97.60%-330M	-137.26%-987M	-246.46%-343M	-211.84%-237M	-110.53%-240M
Non-operating interest income	-37.04%34M	57.62%238M	--0	243.59%134M	47.06%50M	38.46%54M	-31.98%151M	-33.90%39M	-37.10%39M	-20.93%34M
Non-operating interest expense	79.43%689M	68.89%1.92B	61.26%616M	65.58%457M	69.71%465M	86.41%384M	78.37%1.14B	141.77%382M	100.00%276M	74.52%274M
Net investment income	-211.62%-701M	-34.26%-721M	-203.98%-1.07B	92.73%-20M	-404.71%-259M	12,460.00%628M	-185.37%-537M	-191.19%-352M	-278.57%-275M	204.94%85M
Gain(Loss) on financial instruments designated as cash flow hedges		0	0				1.44B	-12M
Gain(Loss) on derecognition of available-for-sale financial assets	0	221.74%140M	-86.00%7M	121.48%29M	456.67%107M	-3M	-139.58%-115M	338.10%50M	-2,600.00%-135M	-130.77%-30M
Income from associates and other participating interests	116.46%39M	69.24%-916M	92.33%-172M	12.58%-264M	-80.00%-243M	20.74%-237M	-5,034.48%-2.98B	-2,569.05%-2.24B	-2,845.45%-302M	-375.51%-135M
Special income (charges)	-722.86%-654M	53.92%-1.76B	92.70%-171M	84.66%-225M	-14,620.00%-1.47B	2,200.00%105M	-215.03%-3.83B	-3,620.63%-2.34B	-139.04%-1.47B	93.59%-10M
Less:Restructuring and mergern&acquisition	--657M	----	----	----	----	----	----	----	----	----
Less:Other special charges	97.14%-3M	1,680.00%267M	7,550.00%153M	11,350.00%225M	-160.00%-6M	-2,200.00%-105M	100.32%15M	104.08%2M	99.96%-2M	433.33%10M
Less:Write off	----	-60.75%1.5B	-99.23%18M	--0	----	----	194.97%3.81B	1,991.07%2.34B	80.25%1.47B	----
Other non-operating income (expenses)	-58.88%44M	361.96%482M	242.59%606M	189.86%400M	-4,953.85%-631M	18.89%107M	-440.74%-184M	-94.06%-425M	-6.76%138M	-80.60%13M
Income before tax	95.23%8.63B	802.81%46.81B	512.29%14.53B	700.57%18.15B	340.53%9.72B	424.05%4.42B	-148.69%-6.66B	-341.14%-3.52B	-67.08%2.27B	-216.86%-4.04B
Income tax	29.12%2.85B	692.76%16.55B	459.07%5.52B	803.45%5.49B	6,693.88%3.33B	397.74%2.21B	-66.53%2.09B	-27.05%987M	-74.12%608M	-96.53%49M
Net income	161.16%5.78B	446.00%30.27B	299.71%9.01B	662.41%12.66B	256.26%6.39B	222.46%2.21B	-217.52%-8.75B	-4,275.93%-4.51B	-63.41%1.66B	-299.90%-4.09B
Net income continuous operations	161.04%5.78B	446.01%30.27B	299.71%9.01B	662.87%12.66B	256.26%6.39B	222.58%2.22B	-217.50%-8.75B	-4,275.93%-4.51B	-63.44%1.66B	-299.90%-4.09B
Noncontrolling interests	-81.82%38M	-24.71%594M	-28.99%240M	-62.99%57M	-34.33%88M	28.22%209M	-23.69%789M	-11.05%338M	-48.49%154M	-42.49%134M
Net income attributable to the company	186.43%5.74B	411.11%29.67B	280.82%8.77B	736.52%12.6B	249.25%6.3B	201.67%2.01B	-248.80%-9.54B	-1,689.30%-4.85B	-64.46%1.51B	-333.06%-4.22B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	186.43%5.74B	411.11%29.67B	280.82%8.77B	736.52%12.6B	249.25%6.3B	201.67%2.01B	-248.80%-9.54B	-1,689.30%-4.85B	-64.46%1.51B	-333.06%-4.22B
Gross dividend payment
Basic earnings per share	185.94%103.14	419.49%533.62	284.16%157.66	821.64%226.54	255.74%113.35	208.61%36.07	-257.54%-167.02	-1,810.94%-85.61	-64.93%24.58	-342.76%-72.78
Diluted earnings per share	185.94%103.14	419.49%533.62	280.74%157.6528	821.60%226.5288	251.71%112.4233	208.61%36.07	-257.54%-167.02	-1,847.01%-87.2259	-64.75%24.58	-348.53%-74.1034
Dividend per share	0	55.88%106	94.12%66	0	17.65%40	0	0.00%68	0.00%34	0	0.00%34
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.